Ware RE - Search Results

1

Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.

Flanagan JM, Steward S, Howard TA, Mortier NA, Kimble AC, Aygun B, Hankins JS, Neale GA, Ware RE. Flanagan JM, et al. Among authors: ware re. Br J Haematol. 2012 Apr;157(2):240-8. doi: 10.1111/j.1365-2141.2012.09061.x. Epub 2012 Feb 24. Br J Haematol. 2012. PMID: 22360576 Free article. Clinical Trial.

2

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.

Heeney MM, Howard TA, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Lab Clin Med. 2003 Apr;141(4):279-82. doi: 10.1067/mlc.2003.28. J Lab Clin Med. 2003. PMID: 12677174 Clinical Trial.

3

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

Heeney MM, Ormsbee SM, Moody MA, Howard TA, DeCastro CM, Ware RE. Heeney MM, et al. Among authors: ware re. Mol Genet Metab. 2003 Apr;78(4):291-4. doi: 10.1016/s1096-7192(03)00047-7. Mol Genet Metab. 2003. PMID: 12706380

4

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.

Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2004 Mar 15;103(6):2039-45. doi: 10.1182/blood-2003-07-2475. Epub 2003 Nov 20. Blood. 2004. PMID: 14630791 Free article. Clinical Trial.

5

Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease.

Jeng MR, Adams-Graves P, Howard TA, Whorton MR, Li CS, Ware RE. Jeng MR, et al. Among authors: ware re. Am J Hematol. 2003 Dec;74(4):243-8. doi: 10.1002/ajh.10426. Am J Hematol. 2003. PMID: 14635204 Free article.

6

Chemical and functional analysis of hydroxyurea oral solutions.

Heeney MM, Whorton MR, Howard TA, Johnson CA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2004 Mar;26(3):179-84. doi: 10.1097/00043426-200403000-00007. J Pediatr Hematol Oncol. 2004. PMID: 15125610

7

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.

Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Ware RE, et al. J Pediatr. 2004 Sep;145(3):346-52. doi: 10.1016/j.jpeds.2004.04.058. J Pediatr. 2004. PMID: 15343189

8

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC. Hankins JS, et al. Among authors: ware re. Blood. 2005 Oct 1;106(7):2269-75. doi: 10.1182/Blood-2004-12-4973. Blood. 2005. PMID: 16172253 Free PMC article. Clinical Trial.

9

Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease.

Harrod VL, Howard TA, Zimmerman SA, Dertinger SD, Ware RE. Harrod VL, et al. Among authors: ware re. Exp Hematol. 2007 Feb;35(2):179-83. doi: 10.1016/j.exphem.2006.09.013. Exp Hematol. 2007. PMID: 17258066 Free article.

10

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2007 Aug 1;110(3):1043-7. doi: 10.1182/blood-2006-11-057893. Epub 2007 Apr 11. Blood. 2007. PMID: 17429008 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters